Director, R&D Digital Enablement jobs in United States
cer-icon
Apply on Employer Site
company-logo

CSL · 2 months ago

Director, R&D Digital Enablement

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. The Director, R&D Digital Enablement will lead digital enablement initiatives across R&D, guiding agile teams and ensuring successful adoption of digital solutions aligned with business needs.

BiotechnologyHealth CareHealth DiagnosticsMedical
check
Comp. & Benefits

Responsibilities

Leads the execution of digital enablement initiatives across R&D by guiding agile teams, driving process transformation, and supporting change management
Acts as a key partner to R&D functions to ensure alignment of digital programs with business needs and successful adoption of digital solutions
Translate digital strategy into executable programs and initiatives across R&D functions
Lead business analysis and partner with stakeholders to identify digital needs and prioritize opportunities
Guide process design, reengineering, and change adoption for digital initiatives
Oversee agile delivery teams and ensure alignment with product owners and stakeholders
Implement change management strategies and user engagement plans to foster adoption
Monitor project impact and value realization through defined KPIs and feedback loops
Contribute to the evolution of digital operating models across the scientific organization

Qualification

Digital transformationAgile program deliveryBusiness analysisStakeholder managementChange managementProcess designJiraConfluenceMiroSmartsheetUser engagementKPI monitoringCommunication skillsTeam leadership

Required

Bachelor's or Master's in Business, Life Sciences, or Technology-related field
10+ years of experience in digital transformation, business analysis, or agile program delivery
Proven success leading agile teams in R&D or scientific organizations
Experience with tools such as Jira, Confluence, Miro, and Smartsheet
Strong communication and stakeholder management skills

Company

CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.

Funding

Current Stage
Public Company
Total Funding
$111M
2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO

Leadership Team

leader-logo
Jeffrey Ball
Chief Sustainability Officer
linkedin
leader-logo
Joy Linton
Strategic Advisor
linkedin
Company data provided by crunchbase